Importantly, we provide an explanation for this observation by showing that this 5-hmc reduction coincides with the downregulation of TET2. Indeed, immunohistochemistry experiments allowed us to document that tumor T cells infiltrating lymph nodes from an acute patient express lower amount of TET2 protein than tumor T cells from a chronic patient. Here, TET2 is linked to neoplasm.